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Abstract
The biological mode of action of artemisinin, a potent antimalarial, has long been controversial. Previously we established a
yeast model addressing its mechanism of action and found mitochondria the key in executing artemisinin’s action. Here we
present data showing that artemisinin directly acts on mitochondria and it inhibits malaria in a similar way as yeast.
Specifically, artemisinin and its homologues exhibit correlated activities against malaria and yeast, with the peroxide bridge
playing a key role for their inhibitory action in both organisms. In addition, we showed that artemisinins are distributed to
malarial mitochondria and directly impair their functions when isolated mitochondria were tested. In efforts to explore how
the action specificity of artemisinin is achieved, we found strikingly rapid and dramatic reactive oxygen species (ROS)
production is induced with artemisinin in isolated yeast and malarial but not mammalian mitochondria, and ROS scavengers
can ameliorate the effects of artemisinin. Deoxyartemisinin, which lacks an endoperoxide bridge, has no effect on
membrane potential or ROS production in malarial mitochondria. OZ209, a distantly related antimalarial endoperoxide, also
causes ROS production and depolarization in isolated malarial mitochondria. Finally, interference of mitochondrial electron
transport chain (ETC) can alter the sensitivity of the parasite towards artemisinin. Addition of iron chelator desferrioxamine
drastically reduces ETC activity as well as mitigates artemisinin-induced ROS production. Taken together, our results indicate
that mitochondrion is an important direct target, if not the sole one, in the antimalarial action of artemisinins. We suggest
that fundamental differences among mitochondria from different species delineate the action specificity of this class of
drugs, and differing from many other drugs, the action specificity of artemisinins originates from their activation
mechanism.
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Introduction
Malaria remains one of the major threats to human health.
Nearly two billion people are at risk and likely more than one
million die of the disease annually. The past years witnessed the
wide emergence of drug-resistant strains in many regions, which
has contributed largely to the resurgence of malaria, an ancient
disease once deemed under control. Artemisinin, derived from the
Chinese herb, Artemisia annua L, is a highly effective drug in our
fight against this devastating disease [1,2]. Its minimal clinical
toxicity and fast action make it the best choice currently available
for drug-resistant strains. Derivatives of artemisinin, including
dihydroartemisinin, artemether, arteether and artesunate, or so
called first generation artemisinin derivatives, were synthesized
and have ever since been used in the treatment of malaria [3].
This class of drugs (artemisinins) contains an intramolecular
peroxide bridge that is situated in the sesquiterpene lactone
backbone structure and is key to the antimalarial function [4].
More recently, semisynthetic and synthetic endoperoxide ana-
logues, some of which deviate distantly in the structural backbone
from that of the original artemisinin were also made and in some
cases associated with even more potent antimalarial effects.
Intriguingly, despite many years of use clinically meaningful
resistance to artemisinin has not yet convincingly been shown.
What is more, near forty years since its discovery and with large
amount of literatures published regarding its mode of action, how
artemisinins inhibit the growth of malarial parasites remains an
enigma and in a state of confusion [5,6].
The key functional part of artemisinins and their analogues is the
endoperoxidic bridge, as demonstrated repeatedly by years of
structural-functional research. One mystery about this class of
endoperoxide drugs is that their backbones can vary dramatically
without losing the antimalarial efficacy (Figure 1). On the other
hand, simple change of molecular hydrophobicity at some
unimportant sites can greatly diminish the drug effect [7]. More
puzzling is that enantiomers of several of these compounds,
including one 1,2,4-trioxanes structurally similar to artemisinin,
have been made and tested against their efficacy on malaria
parasites: all of them displayed no stereoselective difference in
antiparasitic activity between enantiomers [6,8,9]. These pieces of
structure-efficacy information imply that artemisinins may not
achieve their functions through binding specifically to a protein-
target site and consequently inhibiting its function. In other words,
working models of targeting a specific protein for artemisinin’s
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9582action would not fit well with what we already know about the
structure-function relationship for this class of drugs. Clearly, we are
facingaclassofimportantchemicalsthatmayworkinauniqueway.
To help solving these mysteries, i.e., how artemisinins work
and how the excellent specificity towards malaria parasites was
achieved, we previously developed a yeast (Saccharomyces
cerevisiae) model to study the mode of action of artemisinin
[10]. We found that artemisinin inhibits yeast (for convenience,
yeast means S. cerevisiae throughout this work) growth through
interfering with its mitochondrial functions. That mode of
Figure 1. Artemisinin and its antimalarial derivatives include various peroxide compounds. (A) Artemisinin. (B) OZ209 and OZ277. (C–E)
Enantiomers (1a, 1b; 2a, 2b and 3a, 3b) that have been synthesized and shown with no stereoselective difference in antimalarial activity. (F)
Yingzhaosu A. (G and H) Antimalarial tetraoxanes.
doi:10.1371/journal.pone.0009582.g001
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direct biochemical supporting evidence and in particular, awaits
confirmation in malarial parasites. Here, based on former clues
we made in the yeast genetic studies we examined how
artemisinins interact with mitochondria and how they work on
malaria parasites.
Results
The Endoperoxide Bond of Artemisinin Is Key to Its
Action in Yeast as in Malarial Parasites
Among artemisinin analogues with the backbone of the
original artemisinin, corresponding antimalarial activities vary.
In particular, deoxyartemisinin, which maintains all parts of
artemisinin except the peroxide bridge, is ineffective in
inhibiting malaria. We reasoned that if yeast is inhibited by
artemisinin in a similar way as malaria parasites, deoxyartemi-
sinin should not be growth inhibitory in yeast either. We thus
conducted a comparative study between yeast and malarial
parasites with some of these artemisinin analogues, including
deoxyartemisinin, SM248, artemisinin and dihydroartemisinin
(Figure 2A).
As shown in previous work and this study, deoxyartemisinin has
virtually no inhibitory effect on Plasmodium falciparum (Figure 2C).
The inhibitory efficacy of these drugs on P. falciparum is in the
order of (from weak to strong) deoxyartemisinin, SM248,
artemisinin and dihydroartemisinin. Inhibition of yeast by
artemisinins can be complete and potent. To reduce growth by
50% in two days (48 hours) requires about 2–5 ng/ml of
artemisinin in liquid culture [10]. However, to eliminate the
growth of the normal yeast strain on plates requires much higher
dosage. For example, 0.5–1 mg/ml of dihydroartemisinin is
needed to completely suppress the growth of the normal yeast
strain on plates (Figure 2B). This killing concentration is much
higher than that in malaria parasites as we can virtually eradicate
P. falciparum growth in cell culture with 50 folds less of the drug. It
is likely that yeast mitochondrion itself is less sensitive to the action
of artemisinins (by a factor of 10 as shown in isolated mitochondria
experiment described below). Additionally, rapid cell growth (so
more drug is needed to act quickly) and more mitochondria in
yeast than malaria parasites may also contribute to this sensitivity
difference.
Importantly, deoxyartemisinin has virtually no effect on yeast
growth. Even when 100 times more deoxyartemisinin was used,
no appreciable inhibition of yeast was observed (Figure 2B).
The finding of intracellular peroxide bridge as key to the
growth inhibition of both malaria and yeast suggests that
mechanism of action of artemisinin in these two organisms
may indeed share some key features. Worth noting is that a
recent investigation reports that artemisinin’s inhibition of
several other protozoan parasites is weak and peroxide bond
independent [11].
Figure 2. The peroxidic bridge is essential to the inhibitory activity of artemisinin in both yeast and malaria parasites. (A) Molecular
structures of artemisinin and analogues (artemisinins) used in the study. Deoxyartemisinin contains only one O in the otherwise O-O bridge. (B)
Inhibition of yeast growth with artemisinins. Strains of ndi1D and nde1D, with mutated internal and external NADH dehydrogenase (type II complex I)
respectively, exhibit reduced sensitivity to artemisinins. (C) Inhibition of P. falciparum growth by artemisinins in cell culture. Data were shown as
mean 6 SEM.
doi:10.1371/journal.pone.0009582.g002
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in Malaria Parasites and in a Reversible Manner
Since artemisinin works specifically through mitochondria to
achieve its inhibitory functions in yeast [10], we then asked
whether this also happens in malaria. We examined the
mitochondrial membrane potential of malaria parasites (P. berghei)
treated with artemisinin. Previously reported standard scheme of
treatment for malaria-infected mice is 6.2 mg/kg artemisinin
injection everyday. Under this scheme, parasite cell inhibition is
about 90% after 4 days [12]. We adopted this in vivo procedure to
test effects of artemisinin on P. berghei mitochondria. Two hours
after artemisinin administration, erythrocytes were isolated and P.
berghei mitochondrial depolarization could be detected, indicating
artemisinin’s action on mitochondria is fast. A caveat to the
interpretation of this result is that the parasites could be dying so
that they lost mitochondrial membrane potential as a consequence
of the death process. However, we found the loss of membrane
potential was reversible at early stages: after washing off
artemisinin, the mitochondrial membrane potential could mostly
recover, indicating the loss of membrane potential was not
secondary to cell death (Figure 3A). Similar phenomenon was
observed in artemisinin-treated yeast cells (Figure 3B). These data
alone suggest that under in vivo scheme, mitochondrial depolar-
ization induced by artemisinin is an early event and not secondary
to cell death (also see Discussion).
Artemisinin Works Directly on Malarial and Yeast
Mitochondria
To answer whether the depolarization of mitochondria is a
direct or indirect effect, we decided to examine the effect of
artemisinin on isolated mitochondria. Again we used rodent
malaria parasite P. berghei in order to obtain sufficient amount of
mitochondria. Membrane potential was monitored by rhodamine
123 uptake. As shown in Figure 3C, membrane potential of
artemisinin-treated P. berghei mitochondria was much lower than
that of the control mitochondria. Significant, yet incomplete,
depolarization could be observed in the presence of as low as
100 nM artemisinin in less than half an hour. Yeast mitochondria
are less sensitive to the action of artemisinin than that of malaria
parasite. Depolarization could be observed in the presence of
1 mM artemisinin in less than half an hour (Figure 3D). In
accordance with in vivo antimalarial and anti-yeast activity data,
the peroxide bridge plays a key role for the depolarizing action
because deoxyartemisinin was unable to depolarize isolated
malarial and yeast mitochondria even at 8 mM (Figure 3C,D).
It has been shown that artemisinin can react with iron or heme
to generate free radicals. To exclude the possibility that the acting
specificity of artemisinin could be due to possible low amount of
heme or other chemical contamination in the malarial mitochon-
dria preparation, we combined together mitochondria isolated
from CHO cells which stably express mitochondria-targeted
DsRed and from P. berghei, and treated them with 100 nM
artemisinin. DsRed was used as a marker to distinguish CHO
mitochondria from P. berghei mitochondria. Mitochondrial mem-
brane potential was monitored by rhodamine 123. As shown in
Figure 3E, even when incubated together the membrane potential
of CHO mitochondria was not affected while that of P. berghei
mitochondria was decreased. Taken together, these experiments
demonstrated the acting specificity of artemisinin arises from the
intrinsic difference between malarial and mammalian mitochon-
dria.
An often raised concern is about the concentration used during
experiments because conceivably too much drug can cause
unpredictable side effects. Inhibition concentrations, however,
depend heavily on duration of treatment and extent of inhibition.
To inhibit malaria growth in cell culture, depending on criteria
adopted and cell strains, previous published data vary somewhat
but generally about several nMs of artemisinin is required to
inhibit 50% further DNA synthesis of P. falciparum in 24 hours
after one day of prior drug incubation (for a total of two days of
drug treatment time). In our hand, it took about 50 nM to inhibit
more than 90% growth of P. falciparum within two days of drug
addition based on cell proliferation (data not shown). For rodent
malaria P. berghei, it was reported around 50 nM or slightly more
artemisinin is needed for 50% growth inhibition in one day
[13,14], indicating the artemisinin concentration (100 nM) we
used to observe mitochondrial effect in P. berghei within half an
hour is physiological although less than 10 nM of the drug has
been shown to inhibit 50% DNA synthesis of P. falciparum in
24 hours after 24 hours of artemisinin prior treatment.
Artemisinins Are Distributed to Mitochondria
Although the above data indicate artemisinins can directly act
on mitochondria, the next question is whether mitochondria are
readily accessible to artemisinins, i.e., whether artemisinins can
diffuse to mitochondria. Indirect immunofluorescence assay was
utilized to answer this question. P. berghei-infected erythrocytes
were stained with monoclonal anti-artesunate antibody [15],
followed by FITC-conjugated goat anti-mouse IgG (green)
secondary antibody. Figure 4 shows clearly that some of the
green fluorescence signal due to artesunate staining co-localized
with the red fluorescence of mitochondria. This immunofluores-
cence result is consistent with radioisotope observation, whereby
radioactivity was seen in mitochondria as well as many other
membrane structures after malaria parasites were incubated with
radioactive artemisinin [16,17], indicating artemisinins can indeed
target to mitochondria and exerts their functions.
Artemisinins Produce a Large Amount of ROS in Malarial
and Yeast Mitochondria but Not in Mammalian
Mitochondria
As a further effort to characterize how artemisinins work in
detail we attempted to investigate how artemisinins depolarize
mitochondrial membranes. Direct measurement of oxygen
consumption of parasites or isolated malarial mitochondria
revealed that 100 nM artemisnin didn’t inhibit noticeably the
respiratory activity, and if anything, could slightly increase it (data
not shown). Thus it appears that the depolarization is mediated by
contributors other than respiration interference. One likely factor
is ROS. We compared the effects of artemisinin on yeast, malaria
and mammalian mitochondria. Artemisinin treatment of mito-
chondria from malaria parasites or yeast was associated with
dramatic increase of ROS production (Figure 5A,B) while
importantly, it had no observable effect on mammalian mito-
chondria (Figure 5C) even at much higher drug concentrations.
To examine whether this level of ROS would be reasonable or
sufficient to disrupt mitochondrial functions, we compared it to
that produced by Xanthine-xanthine oxidase (X/XO) system in
which ROS was generated to induce depolarization. Xanthine
oxidase converts xanthine to uric acid with the production of
superoxide anion [18] and subsequently other reactive oxygen
intermediates, including hydrogen peroxide, hydroxyl radicals,
and singlet oxygen [19]. X/XO system has been reported to
decrease the transmembrane potential of the energized inner
membrane of rat myocardial mitochondria [20]. The production
of reactive oxygen intermediates can be modulated by the amount
Mode of Action of Artemisinin
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9582Figure 3. Artemisinin acts by depolarizing mitochondrial membrane of malaria parasites and yeast cells. (A,B) Artemisinin treatment
resulted in loss of Dym (mitochondrial membrane potential) in P. berghei (A) and yeast (B). The membrane potential could be mostly recovered by
washing off artemisinin shortly after treatment. Dym was monitored by the fluorescence intensity of DiOC6(3) or rhodamine 123 (Rh123). Higher
fluorescence intensity of stained cells indicates higher Dym. n=5. (C) Effect of artemisinin and deoxyartemisinin on the membrane potential of
isolated malarial mitochondria. Isolated P. berghei mitochondria were incubated with artemisinin or deoxyartemisinin. Loss of membrane potential
was apparent with 100 nM artemisinin treatment but not visible with 8 mM deoxyartemisinin. Dym was assessed by measuring the Dym-dependent
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when incubated with isolated P. berghei mitochondria, generated
ROS that was comparable with artemisinin also had similar
uncoupling ability with artemisinin (Figure 5D,E), indicating the
ROS level associated with artemisinin treatment is sufficiently high
to cause depolarization and damage mitochondrial functions. In
consistent with this in vitro data, DPPD (N,N’-diphenyl-1,4-
phenylenediamine), a ROS scavenger, can antagonize the
antimalarial effect and the depolarizing effect of artemisinin
(Figure 5F,G). Similar result was observed with another ROS
scavenger edaravone (data not shown). ROS scavengers such as
dithiothreitol and alpha-tocopherol have also been reported to
antagonize the antimalarial effect of artemisinin [21]. Deoxyarte-
misinin, which lacks an endoperoxide bridge and has no
antimalarial activity, had no effect on ROS production in malarial
mitochondria (Figure 5H).
The fact that artemisinin produces a large amount of ROS,
which is sufficient to disrupt mitochondrial functions in malarial
and yeast mitochondria, together with the observation that ROS
scavengers antagonize the antimalarial effect of artemisinin suggest
that ROS, as produced in malaria or yeast mitochondria, mediate
alone or together with other free radicals resulted from artemisinin
activation to impair mitochondrial functions. This observation also
indicates that the insensitivity of mammalian cells to the action of
artemisinins does not arise from higher tolerability towards ROS,
but inability to interact with artemisinins to generate significant
amount of free radicals.
OZ209, a Synthetic Trioxolane Structurally Related to
Artemisinin, also Directly Acts on Malarial Mitochondria
Over the years, rich efforts have been devoted to the
development of better antimalarial drug candidates based on the
prototype structure of artemisinin. Notable examples include
OZ277 and OZ209 (Figure 6A), two synthetic peroxide triox-
olanes in which the critical peroxidic pharmacophore of the
artemisinins is present within a 1,2,4-trioxolane rather than a
1,2,4-trioxane heterocycle [22]. As in artemisinins, the intracellu-
lar peroxidic bridge is also critical for the malaria inhibitory
function of these synthetic peroxide trioxolanes, propelling people
thinking they should share some important features in mechanism
of action, and also provide an excellent test ground for the validity
of working models. OZ277 and OZ209 have higher antimalarial
activity than artemisinin, but are two orders of magnitude less
active in inhibiting pfATP6, one previously hypothesized target
protein of artemisinin [23]. As we proposed artemisinin inhibits
malaria by disrupting the normal function of malarial mitochon-
dria, we tested the idea whether the synthetic peroxide trioxolanes
may also affect mitochondrial function. In isolated malarial
mitochondria, OZ209 also induced dramatic ROS production.
In fact, 50 nM OZ209 had similar effect to 100 nM artemisinin in
increasing ROS production and depolarizing mitochondrial
membrane (Figure 6B,C). The observation that synthetic peroxide
trioxolane was associated with more potent ROS induction ability
is consistent with its higher antimalarial activity as observed in cell
culture studies [22]. This indicates that artemisinin and its related
derivative OZ209 kill malaria by a similar mechanism—all
through direct disruption of mitochondrial functions.
Interference of Electron Transport Chain Affects
Artemisinin’s Action
Our prior yeast studies show deletion of genes encoding NADH
dehydrogenase in ETC in yeast reduce the sensitivity to
artemisinin, suggesting that ETC has some interactions with
artemisinin, and probably plays an important role in the activation
of artemisinin [10]. In ETC, electrons originate from electron
donors such as NADH, and ultimately end in the reduction of O2.
This electron flow can be interrupted by various inhibitors at
different steps. In malaria parasites DPI has been shown to inhibit
Figure 4. Artemisinins are distributed to the mitochondria. Immunofluorescence analysis revealed the subcellular localization of artesunate.
Artesunate-treated P. berghei cells were stained with DAPI, Mitotracker Red and monoclonal antibody against artesuate. The top and bottom panels
are cells without or with artesuate treatment, respectively. Some of the artesuate immunofluorescence signal is colocalized with mitochondria. Scale
bar, 5 mm.
doi:10.1371/journal.pone.0009582.g004
uptake of Rh123. n=3. Art, artemisinin. Deoxy-Art, deoxyartemisinin (D) Effect of artemisinin and deoxyartemisinin on membrane potential of
isolated yeast mitochondria. Isolated yeast mitochondria were incubated with 1 mM artemisinin or 8 mM deoxyartemisinin. Dym was assessed by
measuring the Dym-dependent uptake of Rh123. n=3. Art, artemisinin. Deoxy-Art, deoxyartemisinin (E) Artemisinin selectively depolarizes malarial
mitochondria but not CHO mitochondria. Mitochondria isolated from P. berghei and CHO cells were mixed and treated with 100 nM artemisinin.
Artemisinin is not effective on the mammalian mitochondria. n=3. Data were shown as mean 6 SEM. * p,0.05 versus control; ** p,0.01 versus
control.
doi:10.1371/journal.pone.0009582.g003
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PLoS ONE | www.plosone.org 6 March 2010 | Volume 5 | Issue 3 | e9582Figure 5. Artemisinin results in ROS production in the malaria mitochondria but not in mammalian mitochondria. (A–C) Artemisinin
promotes ROS generation in isolated mitochondria from malaria parasites (A) and yeast (B) but not in mammalian mitochondria (C). ROS production
was monitored by measuring DCF fluorescence intensity. (D,E) Comparable amount of ROS generated by X/XO system as artemisinin resulted in
similar degree of uncoupling effect on isolated malarial mitochondria. Dym of isolated P. berghei mitochondria was assessed by measuring the Dym-
dependent uptake of Rh123. ROS production was monitored using dichlorofluorescin diacetate (DCFH-DA) assay. (F) An isobologram for DPI and
artemisinin. Data points above the line indicate antagonism between ROS scavenger DPPD and artemisinin. FIC: fractional inhibitory concentration.
Mode of Action of Artemisinin
PLoS ONE | www.plosone.org 7 March 2010 | Volume 5 | Issue 3 | e9582the activity of NADH dehydrogenase-an equivalent of complex I,
and effectively inhibit the growth of P. falciparum in cell culture
[24]. If the ETC in P. falciparum interacts with artemisinin as in
yeast, we expect that DPI might antagonize the effect of
artemisinin. Indeed, there was antagonism between DPI and
artemisinin (Figure 7A). As a control, chloroquine, a drug that has
probably no direct interaction with mitochondria, was used
together with DPI. Not surprisingly, the combined effect of
chloroquine and DPI was roughly additive (Figure 7B). Similar
effect was also observed with IDP or flavone, two other inhibitors
of NADH dehydrogenase in P. falciparum mitochondria (data not
shown).
To obtain more direct evidence of this interaction, we then
checked whether interference of NADH dehydrogenase activity
affects artemisinin’s effect on isolated malarial mitochondria. As
shown in Figure 7C and 7D, DPI antagonized artemisinin-induced
ROS production and depolarization in isolated malarial mito-
chondria. These data is consistent with prior yeast studies showing
deletion of genes encoding NADH dehydrogenase in electron
transport chain in yeast confer resistance to artemisinin and the
hypothesis that ETC plays an important role in the activation and
action of artemisinin.
Iron has been shown in vitro to be able to interact with
artemisinin and generate free radicals. Iron chelators such as
desferrioxamine (DFO) antagonize the antimalarial effect of
artemisinin in cultures of P. falciparum, indicating iron is connected
to the action of artemisinin [25]. We therefore examined how iron
relates to the ROS production induced by artemisinin in isolated
malarial mitochondria. As shown in Figure 7E and 7F, addition of
iron chelator DFO significantly reduced ETC activity and
artemisinin-induced ROS production, suggesting the key role of
iron in both electron transporting and artemisinin-induced ROS
production (also see Discussion).
Discussion
Model organisms such as yeast, fly and worm have greatly
facilitated our understanding of drug’s action and molecular
natures of many human diseases. In prior work, we established a
yeast model to study the action of artemisinin. Here we present
data showing although some physiological differences exist the
action of artemisinin on malaria does in principle mirror many
aspects of that on yeast: artemisinin can fast act to depolarize the
mitochondrial membrane in malaria parasite as in yeast; rapid and
dramatic reactive oxygen species (ROS) production is induced
with artemisinin in isolated malarial and yeast but not mammalian
mitochondria; inhibition of the NADH dehydrogenase in the
mitochondrial ETC antagonizes the action of artemisinin in
malaria parasite. We also show artemisinin and some homologues
exhibit correlated activities against malaria and yeast, with the
peroxide bridge playing a key role for their inhibitory action.
We propose in both yeast and malaria parasites, mitochondria
play dual roles in the action of artemisinin: the electron transport
chain stimulates artemisinin’s effect, most likely by activating it,
then the locally generated free radicals cause mitochondrial
membrane potential loss and disrupt the normal function of
mitochondria. An easily misread piece of information about our
hypothesis is that artemisinin inhibits ETC. In contrast, our
respiration data demonstrate that under low concentrations of
artemisinin this inhibitory effect, if exists, is negligible. This means
that the loss of membrane potential, a marker of affected
mitochondrial functions, is not due to reduction of ETC activity.
Instead, artemisinin’s effect seems to be mediated by ROS or ROS
together with some other free radicals as a result of artemisinin
reduction. A remotely reminiscent scenario was recently reported
for paraquat, which also interacts with ETC, generates ROS and
inflicts damage to mitochondria [26].
Based on our hypothesis, the specificity of artemisinin is due to
its selective interaction with malarial mitochondria. This interac-
tion generates specifically in malarial mitochondria ROS, a key
factor enabling the execution of the antimalarial effect of
artemisinin. The peroxide bond of these molecules is essential to
the generation of free radicals, and the appropriate lipophilic
nature is naturally important for the drugs to cross membrane and
cytosol to reach mitochondria membrane-a hydrophobic environ-
ment. Thus our hypothesis is largely consistent with the structure-
function findings made through years of medicinal chemistry work
that the backbones of endoperoxide drugs can vary dramatically
without affecting the antimalarial efficacy.
Nevertheless, it remains unknown how exactly artemisinin is
rapidly potentiated by malaria or yeast ETC but not by human or
rodent ETC. Conceivably, the structuring of ETCs or properties
of mitochondrial components in these organisms vary much. For
example, yeast and malaria both possess similar NADH
dehydrogenases which are one-polypeptide proteins and rote-
none-insensitive while NADH dehydrogenases of mammalian cells
are large complexes composed of many different subunits and
rotenone-sensitive. The various structuring of ETCs or properties
of mitochondrial components probably result in different interac-
tion between artemisinin and mitochondria in different organisms.
Because addition of iron chelator desferrioxamine drastically
reduces ETC activity and correspondingly mitigates artemisinin-
induced ROS production in isolated malarial mitochondria, we
speculate the effect of iron and ETC might be the same thing. In
other words, it is possible the iron (iron-sulfur or heme) in the ETC
participates in the action of artemisinins or some subsequent steps
after artemisinin activation (such as propagation of ROS). One
conceivable picture, although remains to be seen, is that the ETC
provides the reductive force for the possible iron-catalyzed
artemisinin activation.
Morphological change in mitochondria has been found to be
one of the earliest ultrastructural changes in artemisinin-treated
malaria parasites [17,27–29]. Notably contrast to the earlier
reports, one recent publication suggested that disruption of the
mitochondrial membrane potential might occur as a downstream
effect of artemisinin-caused cell death as vacuolar change was
discernible four hours after artemisinin treatment whereas
‘‘abnormal’’ rhodamine 123 marked signal was not [30]. In our
hands, partial mitochondrial membrane depolarization is notice-
able in about 30 minutes, significantly earlier than reported
vacuolar changes, after artemisinin treatment of malaria-infected
red blood cells. This rapid action, in addition to the observation of
reversibility of mitochondrial membrane potential after artemisi-
nin withdrawal, suggests that the depolarization is unlikely
secondary to cell death. It is possible that the early depolarization
is only partial and less radical than a more complete loss of
membrane potential secondary to cell death much afterwards
which causes the contradictory reports.
In summary, inspired by the initial findings we made in the
yeast model we explored how artemisinin inhibits malaria
parasites. Our model fundamentally differs from previous thinking
(G) ROS scavenger DPPD and its effect on the depolarizing activity of artemisnin. (H) Deoxyartemisinin has no effect on ROS production in isolated
malaria mitochondria. n=3. Data were shown as mean 6 SEM. *** p,0.0001 versus control,
### p,0.0001 versus Art.
doi:10.1371/journal.pone.0009582.g005
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exert its function: Artemisinin, and possibly all members of this
class of antimalarials that contain the key peroxide bond, on the
contrary may interact with the ETC of malaria parasites, generate
local free radicals, which could impair mitochondrial functions
and eventually lead to cell death. Thus, the action specificity of
artemisinins is achieved through the specific mitochondrial
activation in the malarial parasites or yeast, whereas the damaging
action of the resultant free radicals could be local and
promiscuous. It is clear that some further details of mechanism
remain to be answered and refined. However, our yeast model
combined with malaria studies no doubt open a new avenue in
helping settling the long controversy of action mechanism of
artemisinin, a mysterious antimalarial miracle.
Materials and Methods
Chemicals and Antibody
Artemisinin and dihydroartemisinin were from Chongqing
Holley Holding Co. (Chongqing, China) and Chengdu Okay
Plant & Chemical Co. (Chengdu, China), respectively. Deox-
yartemisinin was prepared from artemisinin by hydrogenation.
SM 248 was synthesized from dihydroartemisinin following the
procedures as mentioned before [31]. Monoclonal antibody
against artemisinin or artesunate was a generous gift from Dr.
Baoming Wang (College of Agronomy and Biotechnology, China
Agricultural University).
Yeast Strains and Growth
Standard yeast media and growth conditions were used.
BY4742 yeast strain was used as the wild type control. nde1D
and ndi1D mutants in BY4742 background were from yeast
deletion library (Invitrogen). For drug testing, wild type and the
two mutant strains were plated on YPGE (2% glycerol and 1%
ethanol as carbon source) agar plates or YPGE plates supple-
mented with different concentrations of artemisinin or its
analogues.
P. falciparum Cultivation
P. falciparum (isolate 3D7) was maintained in vitro by a
modification of the method as described before [32]. The culture
medium adopted was standard RPMI1640 (Invitrogen) supple-
mented with Albumax II (Invitrogen). Cultures were maintained in
human red blood cell suspensions at a hematocrit of 5%. Parasite
density was maintained below 5% parasitemia under an
atmosphere of gas mixture containing 5% CO2,5 %O 2, and
90% N2 at 37uC in a water-jacketed incubator. For the
microfluorimetric method, parasites were further diluted with
culture medium containing sufficient noninfected human erythro-
cytes to yield a final hematocrit of 2% and a parasitemia of 1%.
For synchronized assay, asynchronous cultures of schizont stage
parasites were pretreated with 5% sorbitol.
Fluorimetric Susceptibility Test
Synchronized ring form cultures (hematocrit =2% and
parasitemia =1%) were used to test antimalarial effects in
96-well plates. Cultures of P. falciparum were placed in a
humidified, air-sealed container, flushed with the gas mixture as
described above, and incubated at 37uC. Parasites were allowed
to grow for a 48-hour incubation period. 50 ml fluorochrome
mixture, which consists of SyberGreen I (Invitrogen), 10 mM
Tris-HCl, 1 mM EDTA, pH 7.5 (TE buffer), and 2% Triton X-
100, was then added to 100 ml cultures to liberate and label the
Figure 6. OZ209, a synthetic endoperoxide antimalarial with
structurally different backbone, also affects the malarial
mitochondrial functions. (A) Molecular structures of artemisinin,
OZ209 and OZ277. (B) OZ209 and its effect on the ROS production in
isolated malarial mitochondria. ROS production in isolated P. berghei
mitochondria was monitored by measuring DCF fluorescence intensity.
(C) OZ209 and its depolarizing effect on mitochondrial membrane. Dy
of isolated P. berghei mitochondria was assessed by measuring the Dy-
dependent uptake of Rh123. n=3. Data were shown as mean 6 SEM.
*** p,0.0001 versus control.
doi:10.1371/journal.pone.0009582.g006
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the dark. The fluorescence signal was quantitated at 485 nm
excitation and 538 nm emission by a microplate fluorometer
(Fluoroskan Ascent, Thermo). Simultaneously, the fluorescence
from negative control samples were obtained, stored and
analyzed.
The effect of the interaction between antimalarial agents on the
growth of P. falciparum culture was assessed using isobole analysis
[33]. Isobologram was plotted with mean FIC to determine the
interaction between agents.
Isolation of Mitochondria from P. berghei
P. berghei was maintained in vivo in male mice by weekly transfer
infection. Mitochondria were purified from P. berghei cells by
differential centrifugation and Percoll gradient centrifugation
[34]. Blood was collected in phosphate-buffered saline (PBS),
pH 7.4, containing 10 units of heparin/ml at approximately 60%
parasitemia. Red blood cells were then washed twice in PBS by
centrifugation at 4uC at 1,500 g for 5 min. The parasites were
freed of the host erythrocytes by incubating in PBS with 0.15%
saponin and then washed at least four times. The washed
parasites were resuspended in isolation buffer containing 75 mM
sucrose, 225 mM mannitol, 5 mM MgCl2,5 m MK H 2PO4,
1 mM EGTA, proteinase inhibitor cocktail (Sigma) and 5 mM
Hepes-KOH, pH 7.4. The suspended parasites were broken with
glass homogenizer. To remove nuclei and large membrane
fragments, the homogenate was first centrifuged at 4500 g for
5 min, and the resulting supernate was subsequently centrifuged
Figure 7. Interference of the electron transport chain affects the artemisinin’s action. (A) An isobologram for DPI and artemisinin. Data
points above the line indicate antagonism between DPI and artemisinin. FIC: fractional inhibitory concentration. DPI: diphenylene iodonium chloride.
(B) An isobologram for DPI and chloroquine (CQ). (C) Effect of DPI on the ROS promoting ability of artemisinin. ROS was monitored using the DCFH-
DA assay. (D) Effect of DPI on the depolarizing ability of artemisinin. Dy of isolated P. berghei mitochondria was assessed by measuring the Dy-
dependent uptake of Rh123. (E) Iron chelator DFO inhibits ETC activity. (F) Iron chelator DFO reduces artemisinin-induced ROS production in isolated
malarial mitochondria. n=3. Data were shown as mean 6 SEM. ** p,0.01 versus conrol; *** p,0.001 versus control;
## p,0.01 versus Art.
doi:10.1371/journal.pone.0009582.g007
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The mitochondrial fraction was further purified by a 22% (v/v)
Percoll gradient [34].
Determination of Mitochondrial Membrane Potential
To test the effect of artemisinin on mitochondrial membrane
potential of P. berghei cells, 6.2 mg/kg artemisinin was injected into
malaria-infected mice. 2 hours later blood was collected in
phosphate-buffered saline (PBS), pH 7.4, containing 10 units of
heparin/ml. Red blood cells were washed twice in PBS. The
mitochondrial membrane potential of P. berghei cells was
determined by measuring the fluorescence intensity of DiOC6(3)
using a flow cytometer (FACScan, BD). The infected erythrocytes
were incubated with 2 nM final concentration of DiOC6(3) for
20 min at 37uC. The excitation and emission wavelengths for
DiOC6(3) were 488 and 501 nm respectively. For each sample,
10,000 events were counted at the same flow cytometer setting.
Data were shown in mean fluorescence intensity. For reversibility
testing, artemisinin-treated or untreated erythrocytes were washed
at least three times and then incubated in RMPI 1640 plus
Albumax II for 1 hour.
The mitochondrial membrane potential of yeast cells was
determined by measuring the fluorescence intensity of rhodamine
123 (Rh123). Yeast cells were incubated in YPGE with or without
16 mM artemisinin for 2 hours. At the end of incubation, yeast
cells were incubated with 2 mM Rh123 for 30 min at 30uC before
washing and resuspension. The mitochondrial membrane poten-
tial of yeast cells was determined using a flow cytometer
(FACScan, BD). The excitation and emission wavelengths for
Rh123 were 480 and 530 nm respectively. For each sample,
10,000 events were counted at the same flow cytometer setting.
Data were shown in mean fluorescence intensity. For reversibility
testing, artemisinin-treated or untreated yeast cells were washed at
least three times and incubated in YPG for 30 min prior to the
assay.
Membrane potential of the isolated P. berghei mitochondria was
assessed by measuring the Dy-dependent uptake of Rh123
[35,36]. Isolated mitochondria (1 mg of protein per ml) were
incubated at 30uC in a buffer containing 250 mM sucrose, 5 mM
MgCl2,3 0 m MK H 2PO4, 2 mM EDTA, and 50 mM Tris,
pH 7.4. Dy was assessed by measuring the Dy-dependent uptake
of Rh123 by using a microplate fluorometer (Fluoroskan Ascent,
Thermo) with excitation at 485 nm and emission at 538 nm after
addition of 50 nM Rh123 to the mitochondrial suspension.
To test the specificity of the action of artemisinin on different
mitochondria, mitochondria isolated from CHO cell expressing
mitochondria-targeted DsRed and P. berghei were mixed and
treated with 100 nM artemisinin. DsRed was used as a marker to
distinguish CHO mitochondria and P. berghei mitochondria, and
mitochondrial membrane potential was analyzed by rhodamine
123 intensity using a flow cytometer (FACSVantage Diva, BD).
Determination of ROS Production in Isolated
Mitochondria
ROS production in isolated mitochondria was monitored using
dichlorofluorescin diacetate (DCFH-DA) assay [37]. Isolated
mitochondria (1 mg of protein per ml) were incubated at 30uC
in buffer containing 250 mM sucrose, 5 mM MgCl2,3 0 m M
KH2PO4, 2 mM EDTA, 2 mM a-ketoglutaric acid and 50 mM
Tris, pH 7.4. DCF fluorescence intensity was measured by a
microplate reader (Fluoroskan Ascent) with excitation at 485 nm
and emission at 538 nm after addition of 10 mM DCFH-DA to the
mitochondrial suspension. The relative units of DCF fluorescence
obtained from different samples were reported as the mean6SEM.
Oxygen Consumption
Isolated mitochondrial samples (1 mg of protein per ml) were
incubated at 30uC in buffer containing 75 mM sucrose, 225 mM
mannitol, 5 mM MgCl2, 5 mM KH2PO4, 1 mM EGTA, 0.3 mM
NADH, 5 mM succinate, and 5 mM Hepes-KOH, pH 7.4.
Oxygen consumption of isolated mitochondria was measured
using a Clark-type oxygen electrode in a total volume of 1 ml.
Immunofluorescence Confocal Microscopy
Artesunate-treated or -untreated infected RBCs were washed,
enriched by 60% Percoll gradient, stained with 200 nM
Mitotracker red (Invitrogen) and then attached to polylysine
coated cover slips. The coverslips were fixed in methanol,
permeabilized with 0.05% saponin and blocked overnight in
blocking solution (10% heat-inactivated goat serum in PBS),
followed by overnight incubation in blocking solution containing
monoclonal antibody against artemisinin (dilution 1:500). After
several washes in PBS, the coverslips were incubated in blocking
solution containing FITC-conjugated goat anti-rabbit IgG sec-
ondary antibody (dilution 1:250), washed in PBS, stained with
DAPI (Invitrogen) and examined by Olympus FV500 laser
scanning confocal microscope.
Statistics
Statistical differences between groups were calculated by
Student’s two-tailed t test.
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